Captopril
ACE inhibitor (antihypertensive)
Brand names: Capoten
Oral health effects
Dysgeusia (loss/alteration of taste)
Captopril is classically associated with taste disturbance, attributed to its sulfhydryl group.
Clinical management: Often reversible on dose reduction; coordinate with prescriber.
Angioedema
Class effect: orofacial/airway swelling.
Mechanism: Bradykinin accumulation.
Clinical management: Emergency management if airway involved.
Persistent dry cough (ACE inhibitor cough)
A dry, tickly, non-productive cough is a class effect of ACE inhibitors caused by bradykinin accumulation; it can start weeks to months after starting and resolves within days to weeks of stopping. Label: cough reported in 0.5 to 2% of captopril-treated patients in clinical trials.
Clinical management: Ask about chronic cough at medical history review. Cough can be triggered by water spray, prophy paste or supine positioning: use high-volume suction, a more upright chair position and short breaks. Persistent cough is a reason for the patient to discuss alternatives (e.g. an ARB) with their prescriber; do not advise stopping the medication.
Sources
- A review and guide to drug-associated oral adverse effects-Dental, salivary and neurosensory reactions. Part 1. Teoh L, Moses G, McCullough MJ. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, 2019.
- Adverse drug events in the oral cavity. Yuan A, Woo SB. Oral surgery, oral medicine, oral pathology and oral radiology, 2015.
- Captopril prescribing information (FDA label) AMICI PHARMA, INC. / DailyMed, 2026.
- Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis. Hu Y, Liang L, Liu S, Kung JY, Banh HL. Journal of clinical hypertension (Greenwich, Conn.), 2023.
- Rate of Cough During Treatment With Angiotensin-Converting Enzyme Inhibitors: A Meta-Analysis of Randomized Placebo-Controlled Trials. Vukadinović D, Vukadinović AN, Lavall D, Laufs U, Wagenpfeil S, Böhm M. Clinical pharmacology and therapeutics, 2019.